Comparative Study of the Effects of Azilsartan and Telmisartan on Insulin Resistance and Metabolic Biomarkers in Essential Hypertension Associated With Type 2 Diabetes Mellitus.

Meher, Bikash R; Mohanty, Rashmi R; Sahoo, Jyoti P; Jena, Monalisa; Srinivasan, Anand; Padhy, Biswa M

Meher, Bikash R; Mohanty, Rashmi R; Sahoo, Jyoti P; Jena, Monalisa; Srinivasan, Anand; Padhy, Biswa M.

Afiliación

Meher BR; Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.
Mohanty RR; General Medicine, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.
Sahoo JP; Pharmacology, Srirama Chandra Bhanja (SCB) Medical College and Hospital, Cuttack, IND.
Jena M; Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.
Srinivasan A; Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.
Padhy BM; Pharmacology, All India Institute of Medical Sciences, Bhubaneswar, Bhubaneswar, IND.

Cureus ; 14(2): e22301, 2022 Feb.

Article en En | MEDLINE | ID: mdl-35350513

Palabras clave

azilsartan; biochemical markers; diabetes mellitus; hypertension; insulin resistance; telmisartan

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Cureus Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google